{"id":"https://openalex.org/W4390129248","doi":"https://doi.org/10.1016/j.jval.2023.09.2589","title":"PCR151 Health Related Quality of Life (HRQOL) Among Patients with Transthyretin Amyloidosis (ATTR): A Systematic Literature Review","display_name":"PCR151 Health Related Quality of Life (HRQOL) Among Patients with Transthyretin Amyloidosis (ATTR): A Systematic Literature Review","publication_year":2023,"publication_date":"2023-12-01","ids":{"openalex":"https://openalex.org/W4390129248","doi":"https://doi.org/10.1016/j.jval.2023.09.2589"},"language":"en","primary_location":{"id":"doi:10.1016/j.jval.2023.09.2589","doi":"https://doi.org/10.1016/j.jval.2023.09.2589","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2023.09.2589","pdf_url":"https://www.valueinhealthjournal.com/article/S1098-3015(23)05719-4/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.valueinhealthjournal.com/article/S1098-3015(23)05719-4/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077963668","display_name":"D. Delgado","orcid":"https://orcid.org/0000-0003-0230-553X","observed_orcids":["https://orcid.org/0000-0003-0230-553X"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"D. Delgado","raw_affiliation_strings":["Division of Cardiology and Transplant, UHN, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cardiology and Transplant, UHN, Toronto, ON, Canada","institution_ids":["https://openalex.org/I1325899441"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002637741","display_name":"Nitin Shivappa","orcid":"https://orcid.org/0000-0003-0441-8896","observed_orcids":["https://orcid.org/0000-0003-0441-8896"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. Shivappa","raw_affiliation_strings":["Cardiovascular, Renal and Metabolism (CVRM) Evidence, BioPharmaceuticals Medical, AstraZeneca, Spring City, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular, Renal and Metabolism (CVRM) Evidence, BioPharmaceuticals Medical, AstraZeneca, Spring City, PA, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003654110","display_name":"Firas Dabbous","orcid":"https://orcid.org/0000-0002-0823-6099","observed_orcids":["https://orcid.org/0000-0002-0823-6099"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Dabbous","raw_affiliation_strings":["Data Analytics, Real World Evidence, Evidera, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Data Analytics, Real World Evidence, Evidera, IL, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001561903","display_name":"Divya Shridharmurthy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Shridharmurthy","raw_affiliation_strings":["Data Analytics, Real World Evidence, Evidera, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Data Analytics, Real World Evidence, Evidera, IL, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037280177","display_name":"Krister J\u00e4rbrink","orcid":"https://orcid.org/0000-0003-2612-1233","observed_orcids":["https://orcid.org/0000-0003-2612-1233"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"K. Jarbrink","raw_affiliation_strings":["Cardiovascular, Renal and Metabolism (CVRM) Evidence, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular, Renal and Metabolism (CVRM) Evidence, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3200,"currency":"USD","value_usd":3200},"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.01032807,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":"12","first_page":"S477","last_page":"S478"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/transthyretin-amyloidosis","display_name":"transthyretin amyloidosis","score":1.0},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.996999979019165},{"id":"https://openalex.org/keywords/quality-of-life-instruments","display_name":"quality of life instruments","score":0.8019999861717224},{"id":"https://openalex.org/keywords/polyneuropathy","display_name":"polyneuropathy","score":0.8709999918937683},{"id":"https://openalex.org/keywords/cardiomyopathy","display_name":"cardiomyopathy","score":0.9610000252723694},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.6779999732971191}],"concepts":[{"id":"https://openalex.org/C121157162","wikidata":"https://www.wikidata.org/wiki/Q419999","display_name":"Transthyretin","level":2,"score":0.8110992312431335},{"id":"https://openalex.org/C2779951007","wikidata":"https://www.wikidata.org/wiki/Q816798","display_name":"Amyloidosis","level":2,"score":0.6840530037879944},{"id":"https://openalex.org/C3019006561","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Health related quality of life","level":3,"score":0.5838022232055664},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5125126838684082},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.5072224140167236},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3247908651828766},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2573724389076233},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.09719964861869812},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.05057963728904724}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jval.2023.09.2589","doi":"https://doi.org/10.1016/j.jval.2023.09.2589","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2023.09.2589","pdf_url":"https://www.valueinhealthjournal.com/article/S1098-3015(23)05719-4/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jval.2023.09.2589","doi":"https://doi.org/10.1016/j.jval.2023.09.2589","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2023.09.2589","pdf_url":"https://www.valueinhealthjournal.com/article/S1098-3015(23)05719-4/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4390129248.pdf","grobid_xml":"https://content.openalex.org/works/W4390129248.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4417482167","https://openalex.org/W2954931699","https://openalex.org/W2810865263","https://openalex.org/W7128729396","https://openalex.org/W4383550403","https://openalex.org/W2956017697","https://openalex.org/W3161053378","https://openalex.org/W7166047724","https://openalex.org/W4353018188","https://openalex.org/W4389464217"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-12-23T00:00:00"}